1.
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION: KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse. Mediterr J Hematol Infect Dis [Internet]. 2021 Jan. 1 [cited 2026 Apr. 19];13(1):e2021005 . Available from: https://www.mjhid.org/mjhid/article/view/4363